Patents by Inventor Satish Kumar Jain
Satish Kumar Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11523996Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: GrantFiled: November 1, 2017Date of Patent: December 13, 2022Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
-
Patent number: 11504345Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: GrantFiled: June 23, 2020Date of Patent: November 22, 2022Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
-
Publication number: 20200315994Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: ApplicationFiled: June 23, 2020Publication date: October 8, 2020Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20180221290Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.Type: ApplicationFiled: April 2, 2018Publication date: August 9, 2018Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20180193299Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.Type: ApplicationFiled: March 6, 2018Publication date: July 12, 2018Inventors: Rajesh RAO, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH
-
Patent number: 9999606Abstract: An oral pharmaceutical composition of isotretinoin and a carrier substrate, having isotretinoin in the form of gel, dispersion, solution or emulsion, which is absorbed onto the carrier substrate to form solid particles, powder, or granules. The oral pharmaceutical composition has enhanced bioavailability. A process is used for preparing the oral composition.Type: GrantFiled: December 3, 2015Date of Patent: June 19, 2018Assignee: Sun Pharmaceutical Industries Limited.Inventors: Rajesh Rao, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh
-
Patent number: 9962336Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.Type: GrantFiled: May 6, 2016Date of Patent: May 8, 2018Assignee: Sun Pharmaceutical Industries LimitedInventors: Romi Barat Singh, Ashish Kumar, Rajesh Srikrishan Shear, Satish Kumar Jain, Paras P. Jain
-
Publication number: 20180104197Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: ApplicationFiled: May 2, 2016Publication date: April 19, 2018Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20180064663Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: ApplicationFiled: November 1, 2017Publication date: March 8, 2018Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20170304234Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling agent, wherein the coated cores are dispersed in a suspension base. Said extended release liquid compositions provide the desired uniform extended release profile throughout the shelf-life of the composition. Furthermore, said extended release liquid compositions are bioequivalent to a reference composition. It also relates to processes for the preparation of said extended release liquid compositions.Type: ApplicationFiled: May 2, 2016Publication date: October 26, 2017Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20170258748Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.Type: ApplicationFiled: May 24, 2017Publication date: September 14, 2017Inventors: Rajesh RAO, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH
-
Patent number: 9700535Abstract: An oral pharmaceutical composition of isotretinoin with reduced food effect. A process for preparing the oral pharmaceutical composition of the present invention.Type: GrantFiled: December 3, 2015Date of Patent: July 11, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Rajesh Rao, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh
-
Patent number: 9566287Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.Type: GrantFiled: February 2, 2016Date of Patent: February 14, 2017Assignee: Sun Pharmaceutical Industries LimitedInventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
-
Patent number: 9561242Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.Type: GrantFiled: February 2, 2016Date of Patent: February 7, 2017Assignee: Sun Pharmaceutical Industries LimitedInventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
-
Patent number: 9463196Abstract: The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.Type: GrantFiled: August 7, 2015Date of Patent: October 11, 2016Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Ravish Kumar Sharma, Pulak Kumar Metia, Ravinder Singh, Rajesh Srikrishan Shear, Anuj Kumar Fanda, Satish Kumar Jain, Romi Barat Singh, Swarna Pappu, Prabhakar Konatham, Pruthvipathy Katikaneni, Dileep Jami
-
Publication number: 20160271070Abstract: The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active ingredient by using a suspension base, wherein the suspension base ensures substantially similar in-vitro dissolution release profile of the active ingredient upon storage of the suspension compositions for at least seven days.Type: ApplicationFiled: May 6, 2016Publication date: September 22, 2016Inventors: Romi Barat SINGH, Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Paras P. JAIN
-
Publication number: 20160228360Abstract: The present invention relates to extended release liquid compositions of metformin. The extended release liquid compositions are in the form of suspensions or reconstituted powder for suspensions. Said extended release liquid compositions comprise cores of metformin coated with a release-controlling polymer, wherein the cores are dispersed in a suspension base. It also relates to processes for the preparation of said extended release liquid compositions.Type: ApplicationFiled: April 20, 2016Publication date: August 11, 2016Inventors: Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Romi Barat SINGH, Paras P. JAIN
-
Publication number: 20160228379Abstract: The present invention relates to extended release suspension compositions of an active ingredient. Said extended release suspension compositions comprise multiple coated cores of the active ingredient and a suspension base, wherein the suspension base generates a hypertonic condition such that there is no substantial change in the in-vitro dissolution release profile of the extended release suspension compositions upon storage for at least seven days. The invention also relates to processes for the preparation of said extended release suspension compositions.Type: ApplicationFiled: April 20, 2016Publication date: August 11, 2016Inventors: Ashish KUMAR, Rajesh Srikrishan SHEAR, Satish Kumar JAIN, Romi Barat SINGH, Paras P. JAIN
-
Publication number: 20160151396Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.Type: ApplicationFiled: February 2, 2016Publication date: June 2, 2016Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI
-
Publication number: 20160151397Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.Type: ApplicationFiled: February 2, 2016Publication date: June 2, 2016Inventors: Ravish Kumar SHARMA, Pulak Kumar METIA, Ravinder SINGH, Rajesh Srikrishan SHEAR, Anuj Kumar FANDA, Satish Kumar JAIN, Romi Barat SINGH, Swarna PAPPU, Prabhakar KONATHAM, Pruthvipathy KATIKANENI, Dileep JAMI